(Q42440320)

English

Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimer

scientific article published on July 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 October 2017

Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimer (English)

1 reference

Europe PubMed Central

31 October 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Choi CY

1

1 reference

Europe PubMed Central

31 October 2017

Choi BH

2

1 reference

Europe PubMed Central

31 October 2017

Park GT

3

1 reference

Europe PubMed Central

31 October 2017

Rho HM

4

1 reference

Europe PubMed Central

31 October 2017

language of work or name

0 references

publication date

1 July 1997

1 reference

Europe PubMed Central

31 October 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

31 October 2017

272

1 reference

Europe PubMed Central

31 October 2017

27

1 reference

Europe PubMed Central

31 October 2017

16934-16939

1 reference

Europe PubMed Central

31 October 2017

The molecular biology of the hepatitis B viruses

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Release of the hepatitis B virus-associated DNA polymerase from the viral particle by the proteolytic cleavage

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

The retinoblastoma gene product activates transcription of the hepatitis B virus pregenomic promoter through the Sp1 binding sites

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Regulation of hepatitis B virus gene expression by its two enhancers

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Use of the polymerase chain reaction for the sensitive detection of St. Louis encephalitis viral RNA

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Replication of a mutant hepatitis B virus with a fused X-C reading frame in hepatoma cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Effect of frameshift mutation in the pre-C region of hepatitis B virus on the X and C genes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

A positive regulatory sequence of hepatitis B viral small X promoter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

A novel expression selection approach allows precise mapping of the hepatitis B virus enhancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Cellular factors that interact with the hepatitis B virus enhancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Regulation of hepatitis B virus ENI enhancer activity by hepatocyte-enriched transcription factor HNF3.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Functional organization of the hepatitis B virus enhancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Characterization of the role of individual protein binding motifs within the hepatitis B virus enhancer I on X promoter activity using linker scanning mutagenesis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

An NF1 motif plays a central role in hepatitis B virus enhancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

The nucleotide sequence and reading frames of a mutant hepatitis B virus subtype adr.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

The CREB family of transcription activators

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Three sites of the hepatitis B virus X protein cooperatively interact with cellular proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Cyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

A liver-specific enhancer in the core promoter region of human hepatitis B virus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Characterization of a “silencer” in yeast: A DNA sequence with properties opposite to those of a transcriptional enhancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Mutually exclusive interaction of the CCAAT-binding factor and of a displacement protein with overlapping sequences of a histone gene promoter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

The hepatitis B virus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.27.16934

21 January 2018

Identifiers

10.1074/JBC.272.27.16934

1 reference

Europe PubMed Central

31 October 2017

1 reference

Europe PubMed Central

31 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42440320&oldid=1957069759"